Kurs
+1,04%
Likviditet
0,17 MSEK
Kalender
| Est. tid* | ||
| 2026-02-11 | 10:30 | Bokslutskommuniké 2025 |
| 2025-11-12 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-27 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-30 | N/A | X-dag ordinarie utdelning QLIFE 0.00 SEK |
| 2025-05-28 | N/A | Årsstämma |
| 2025-05-20 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-03-21 | - | Extra Bolagsstämma 2025 |
| 2025-02-12 | - | Bokslutskommuniké 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-07-30 | - | Split QLIFE 2000:1 |
| 2024-05-28 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-08 | - | X-dag ordinarie utdelning QLIFE 0.00 SEK |
| 2024-05-07 | - | Årsstämma |
| 2024-02-08 | - | Bokslutskommuniké 2023 |
| 2024-01-16 | - | Extra Bolagsstämma 2023 |
| 2023-11-13 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-26 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-05 | - | X-dag ordinarie utdelning QLIFE 0.00 SEK |
| 2023-05-04 | - | Årsstämma |
| 2023-03-24 | - | Extra Bolagsstämma 2022 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | - | X-dag ordinarie utdelning QLIFE 0.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-08 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | X-dag ordinarie utdelning QLIFE 0.00 SEK |
| 2021-05-05 | - | Årsstämma |
| 2021-05-05 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-19 | - | Extra Bolagsstämma 2020 |
| 2020-11-18 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-22 | - | X-dag ordinarie utdelning QLIFE 0.00 SEK |
| 2020-05-20 | - | Årsstämma |
| 2020-05-20 | - | Kvartalsrapport 2020-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Today, February 15, Qlife opened the Egoo Health webshop for the Egoo system with CRP Capsule. The Egoo CRP Capsule is the first product in Qlife's Egoo portfolio to be introduced to the home market. Both system and capsules can be ordered on
Today, February 15, Qlife opened the Egoo Health webshop for the Egoo system with CRP Capsule. The Egoo CRP Capsule is the first product in Qlife's Egoo portfolio to be introduced to the home market. Both system and capsules can be ordered on https://www.egoo.health/egoo-shop
"With this launch, Qlife really can start delivering on our vision of bringing lifestyle biomarker testing with quantitative precise data to a wider health-conscious audience and for home use", says Thomas Warthoe, CEO of Qlife. "Based on Qlife's own information, this is the world's first self-test platform for immuno-diagnostics biomarkers."
CRP capsules are available as single orders or as subscriptions and initially launched without medical claims. Qlife will file for CE-mark, which allows for broader clinical applicability of the platform.
Qlife was founded based on the idea that Egoo Health could help people lead a better life by using the diagnostics self-testing platform Egoo Health, Empowering a Better Being.
Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34